Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration

Goedert, 2001, Alpha-synuclein and neurodegenerative diseases, Nat. Rev. Neurosci., 2, 492, 10.1038/35081564

Stefanis, 2012, Alpha-synuclein in Parkinson's disease, Cold Spring Harb. Perspect. Med., 2, a009399, 10.1101/cshperspect.a009399

Kiely, 2013, Alpha-synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?, Acta Neuropathol., 125, 753, 10.1007/s00401-013-1096-7

Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, 276, 2045, 10.1126/science.276.5321.2045

Kruger, 1998, Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease, Nat. Genet., 18, 106, 10.1038/ng0298-106

Zarranz, 2004, The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia, Ann. Neurol., 55, 164, 10.1002/ana.10795

Conway, 1998, Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease, Nat. Med., 4, 1318, 10.1038/3311

Yonetani, 2009, Conversion of wild-type alpha-synuclein into mutant-type fibrils and its propagation in the presence of A30P mutant, J. Biol. Chem., 284, 7940, 10.1074/jbc.M807482200

Braak, 2001, Alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei, Acta Neuropathol., 101, 195, 10.1007/s004010000247

Muller, 2005, Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability, J. Neuropathol. Exp. Neurol., 64, 623, 10.1097/01.jnen.0000171652.40083.15

Braak, 2003, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol. Aging, 24, 197, 10.1016/S0197-4580(02)00065-9

Ulusoy, 2013, Caudo-rostral brain spreading of alpha-synuclein through vagal connections, EMBO Mol. Med., 5, 1051, 10.1002/emmm.201302475

Bancher, 1993, Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients, Neurosci. Lett., 162, 179, 10.1016/0304-3940(93)90590-H

Chu, 2010, Lewy body pathology in fetal grafts, Ann. N. Y. Acad. Sci., 1184, 55, 10.1111/j.1749-6632.2009.05229.x

Li, 2008, Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation, Nat. Med., 14, 501, 10.1038/nm1746

Kordower, 2011, Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat, Neurobiol. Dis., 43, 552, 10.1016/j.nbd.2011.05.001

Hansen, 2011, Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells, J. Clin. Invest., 121, 715, 10.1172/JCI43366

Volpicelli-Daley, 2011, Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death, Neuron, 72, 57, 10.1016/j.neuron.2011.08.033

Freundt, 2012, Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport, Ann. Neurol., 72, 517, 10.1002/ana.23747

Holmes, 2013, Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds, Proc. Natl. Acad. Sci. U. S. A., 110, E3138, 10.1073/pnas.1301440110

Luk, 2012, Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice, Science, 338, 949, 10.1126/science.1227157

Recasens, 2014, Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys, Ann. Neurol., 75, 351, 10.1002/ana.24066

Masuda-Suzukake, 2013, Prion-like spreading of pathological alpha-synuclein in brain, Brain, 136, 1128, 10.1093/brain/awt037

Pan-Montojo, 2012, Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice, Sci. Rep., 2, 898, 10.1038/srep00898

Antony, 2011, Parkinson's disease mouse models in translational research, Mamm. Genome, 22, 401, 10.1007/s00335-011-9330-x

Koprich, 2010, Mol. Neurodegener., 5, 43, 10.1186/1750-1326-5-43

Gombash, 2013, Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system, PLoS One, 8, e81426, 10.1371/journal.pone.0081426

Whishaw, 2001, Accelerated nervous system development contributes to behavioral efficiency in the laboratory mouse: a behavioral review and theoretical proposal, Dev. Psychobiol., 39, 151, 10.1002/dev.1041

Gibbs, 2004, Genome sequence of the Brown Norway rat yields insights into mammalian evolution, Nature, 428, 493, 10.1038/nature02426

Lin, 1995, Species similarities and differences in pharmacokinetics, Drug Metab. Dispos., 23, 1008

Volpicelli-Daley, 2014, Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates, Nat. Protoc., 9, 2135, 10.1038/nprot.2014.143

Schallert, 2006, Behavioral tests for preclinical intervention assessment, NeuroRx, 3, 497, 10.1016/j.nurx.2006.08.001

Spieles-Engemann, 2010, Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss, Neurobiol. Dis., 39, 105, 10.1016/j.nbd.2010.03.009

Basken, 2012, Effect of aging on ultrasonic vocalizations and laryngeal sensorimotor neurons in rats, Exp. Brain Res., 219, 351, 10.1007/s00221-012-3096-6

Bialy, 2000, Precontact 50-kHz vocalizations in male rats during acquisition of sexual experience, Behav. Neurosci., 114, 983, 10.1037/0735-7044.114.5.983

Ringel, 2013, Dopamine D1 and D2 receptor antagonism effects on rat ultrasonic vocalizations, Behav. Brain Res., 252, 252, 10.1016/j.bbr.2013.06.006

Gombash, 2014, Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways, Gene Ther., 21, 682, 10.1038/gt.2014.42

Kelenyi, 1967, Thioflavin S, fluorescent and Congo red anisotropic stainings in the histologic demonstration of amyloid, Acta Neuropathol., 7, 336, 10.1007/BF00688089

Gundersen, 1999, The efficiency of systematic sampling in stereology — reconsidered, J. Microsc., 193, 199, 10.1046/j.1365-2818.1999.00457.x

Koprich, 2003, Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat, Brain Res. Dev. Brain Res., 147, 177, 10.1016/S0165-3806(03)00219-0

Koprich, 2003, Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats, Neurotoxicol. Teratol., 25, 509, 10.1016/S0892-0362(03)00091-6

Kirik, 2002, Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system, J. Neurosci., 22, 2780, 10.1523/JNEUROSCI.22-07-02780.2002

Double, 2010, Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?, Prog. Neurobiol., 92, 316, 10.1016/j.pneurobio.2010.06.001

Kanaan, 2008, Age-related changes in dopamine transporters and accumulation of 3-nitrotyrosine in rhesus monkey midbrain dopamine neurons: relevance in selective neuronal vulnerability to degeneration, Eur. J. Neurosci., 27, 3205, 10.1111/j.1460-9568.2008.06307.x

Wall, 2013, Differential innervation of direct- and indirect-pathway striatal projection neurons, Neuron, 79, 347, 10.1016/j.neuron.2013.05.014

Sacino, 2014, Brain injection of alpha-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker, J. Neurosci., 34, 12368, 10.1523/JNEUROSCI.2102-14.2014

McNaught, 2010, The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease, Synapse, 64, 241, 10.1002/syn.20719

Pasquier, 1977, Dorsal raphe, substantia nigra and locus coeruleus: interconnections with each other and the neostriatum, Brain Res. Bull., 2, 323, 10.1016/0361-9230(77)90066-1

Taguchi, 2014, Differential expression of alpha-synuclein in hippocampal neurons, PLoS One, 9, e89327, 10.1371/journal.pone.0089327

Breydo, 1822, Alpha-synuclein misfolding and Parkinson's disease, Biochim. Biophys. Acta, 2012, 261

Marinus, 2015, The significance of motor (A)symmetry in Parkinson's disease, Mov. Disord., 30, 379, 10.1002/mds.26107

Nandhagopal, 2009, Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study, Brain, 132, 2970, 10.1093/brain/awp209

Decressac, 2012, Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons, Neurobiol. Dis., 45, 939, 10.1016/j.nbd.2011.12.013

Decressac, 2012, Comparison of the behavioural and histological characteristics of the 6-OHDA and alpha-synuclein rat models of Parkinson's disease, Exp. Neurol., 235, 306, 10.1016/j.expneurol.2012.02.012

Ciucci, 2009, Reduction of dopamine synaptic activity: degradation of 50-kHz ultrasonic vocalization in rats, Behav. Neurosci., 123, 328, 10.1037/a0014593

Ciucci, 2007, Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study, Behav. Brain Res., 182, 284, 10.1016/j.bbr.2007.02.020

Carneiro, 2014, Quality of life related to swallowing in Parkinson's disease, Dysphagia, 29, 578, 10.1007/s00455-014-9548-3

Grant, 2014, Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease, Behav. Neurosci., 128, 110, 10.1037/a0035965

Ciucci, 2008, Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training, Parkinsonism Relat. Disord., 14, S172, 10.1016/j.parkreldis.2008.04.027